Trading Signals: CYDY Stock Price Prediction and Forecast (Tue. Jul. 21, 2020 - Tue. Feb. 14, 2023)(CytoDyn Inc. )
| CYDY latest price $5.6100 (-6.66%) ($5.6000 - $7.7000) on Wed. Feb. 10, 2021. | |
| | Trend Analysis and Forecast | | | | Average Daily Percentage Swing | 13.09% (three month average) | | RSI | 0 | | Latest Price | $5.6100(-6.66%) | | Stocks Behave Similarly | Similar Stock List | | Daily Trend | CYDY advances 0.2% a day on average for past five trading days. | | Market Behavior | Normal for large cap. Growth stock sell-off for small cap. | | Correlated ETFs | Broad market will support CYDY advance at 0% a week (0% probability)
VXX(48%) SMH(71%) XLU(39%) SLV(35%) SIL(33%) | | Factors Impacting CYDY price | CYDY will decline at least -6.545% in a week (0% probabilities).
XRT(-19%) IDRV(-14%) IBB(-2%) IWC(2%) IWO(-1%) | | Explanation | The rally is not sustainable and not supported by the broad market. | | | | | | | | Relative Volatility | | | | | | Market Trend Strength | -6.545% (StdDev 13.09%) | | Hourly BBV | 0 () | | Intraday Trend | -3.3% | | | | | |
|
| 5 Day Moving Average | $6.15(-8.78%) | | 10 Day Moving Average | $5.66(-0.88%) | | 20 Day Moving Average | $5.47(2.56%) | | To recent high | -16.9% | | To recent low | 9.1% | | Market Cap | $2.911b | | | | | | |
CytoDyn, Inc. is a clinical-stage biotechnology company, which engages in the development of innovative treatments for multiple therapeutic indications based on leronlimab. Its product include HIV, cancer, graft-versus-host disease (GVHD), and PCa test. The company was founded by Allen D. Allen on May 2, 2002 and is headquartered in Vancouver, WA. |